Back
Cartesian Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
29
RNAC
Cartesian Therapeutics
Last Price:
$11.49
Seasonality Move:
4.91%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNAC is experiencing slight selling pressure.
Cartesian Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.35 | Buy |
| 20-day SMA: | 12.23 | Sell |
| 50-day SMA: | 11.53 | Buy |
| 200-day SMA: | 15.19 | Sell |
| 8-day EMA: | 11.51 | Buy |
| 20-day EMA: | 11.88 | Sell |
| 50-day EMA: | 11.83 | Sell |
| 200-day EMA: | 14.23 | Sell |
Cartesian Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.19 | Sell |
| Relative Strength Index (14 RSI): | 48.33 | Sell |
| Chaikin Money Flow: | -5442 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.5 - 13.42) | Sell |
| Bollinger Bands (100): | (9.86 - 13.06) | Buy |
Cartesian Therapeutics Technical Analysis
| Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | Aug | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cartesian Therapeutics Stock
Is Cartesian Therapeutics Stock a Buy?
-
Cartesian Therapeutics share price is 11.71 while RNAC 8-day simple moving average is 11.35, which is a Buy signal.
-
The stock price of RNAC is 11.71 while Cartesian Therapeutics 20-day SMA is 12.23, which makes it a Sell.
-
Cartesian Therapeutics 50-day simple moving average is 11.53 while RNAC share price is 11.71, making it a Buy technically.
-
RNAC stock price is 11.71 and Cartesian Therapeutics 200-day simple moving average is 15.19, creating a Sell signal.
RNAC Technical Analysis vs Fundamental Analysis
Sell
29
Cartesian Therapeutics (RNAC)
is a Sell
Is Cartesian Therapeutics a Buy or a Sell?
-
Cartesian Therapeutics stock is rated a SellThe current Cartesian Therapeutics [RNAC] share price is $11.71. The Score for RNAC is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
Cartesian Therapeutics Stock Info
Market Cap:
304.5M
Price in USD:
11.71
Share Volume:
62.5K
Cartesian Therapeutics 52-Week Range
52-Week High:
26.50
52-Week Low:
8.46
Sell
29
Cartesian Therapeutics (RNAC)
is a Sell
Cartesian Therapeutics Share Price Forecast
-
What is the Cartesian Therapeutics stock price today?The Cartesian Therapeutics stock price is 11.71 USD today.
-
Will RNAC stock go up or go down?Cartesian Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Cartesian Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cartesian Therapeutics is overvalued.
Is Cartesian Therapeutics Stock a Buy?
-
Cartesian Therapeutics share price is 11.71 while RNAC 8-day exponential moving average is 11.51, which is a Buy signal.
-
The stock price of RNAC is 11.71 while Cartesian Therapeutics 20-day EMA is 11.88, which makes it a Sell.
-
Cartesian Therapeutics 50-day exponential moving average is 11.83 while RNAC share price is 11.71, making it a Sell technically.
-
RNAC stock price is 11.71 and Cartesian Therapeutics 200-day simple moving average is 14.23, creating a Sell signal.
Fundamental Analysis of Cartesian Therapeutics
Is Cartesian Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.01 per share, and a decrease next year of $0.76 per share.
Technical Analysis of Cartesian Therapeutics
Should I short Cartesian Therapeutics stock?
-
RNAC Moving Average Covergence Divergence (MACD) indicator is -0.19, suggesting Cartesian Therapeutics is a Sell
-
Cartesian Therapeutics Relative Strength Index (RSI) is 48.33, which suggest Cartesian Therapeutics is oversold
-
The Bollinger Bands (25) for Cartesian Therapeutics is (11.5 - 13.42), which suggest Cartesian Therapeutics is a Buy
-
The Bollinger Bands (100) for Cartesian Therapeutics is (9.86 - 13.06), which suggest Cartesian Therapeutics is a Buy
* Cartesian Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.